What is ALS, also known as Lou Gehrig's disease?

• by Laura Ungar

• February 20, 2026

FDA Reshapes Drug Testing Approach

The agency outlined early regulatory actions supporting nonanimal methods, including draft guidance, artificial intelligence tools, and expanded use of human-relevant data models.

• by Kathryn Wighton

• April 20, 2026

• 2 min

Rejo P. Cherian, M.D., Joins Marcus Neuroscience Institute as a Neurologist

Neurologist Rejo P. Cherian, M.D., who specializes in neuromuscular medicine, has joined Marcus Neuroscience Institute, part of Baptist Health Brain & Spine Care

• by

• July 9, 2026

• 2 min

Multimodal Brain Monitoring May Improve ICU Outcomes

Integrated neuromonitoring approaches may help identify neurologic complications earlier in patients admitted to ICU.

• by Andrea Surnit

• May 7, 2026

• 3 min